T1	Participants 118 145	European multicentre trial.
T2	Participants 232 314	230 patients with endoscopically documented gastric (71) or duodenal (159) ulcers.
T3	Participants 315 392	Gastric ulcer patients who satisfied all criteria for inclusion and exclusion
T4	Participants 1138 1183	treatment of duodenal and gastric ulceration.
